ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,973Medicare Part D Prescriptions Filled, Including Refills

Rank: 169 out of 2588

$902K Total Retail Price of All Prescriptions

Rank: 112 out of 2588

400 Patients Receiving at Least One Drug in Part D
54%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

20% of this provider’s 400 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 9,579 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

40% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
NEXIUM 507 293 1 41
IBUPROFEN 481 294 2 62
CRESTOR 465 318 3 25
METOPROLOL SUCCINATE 450 380 4 12
LOVAZA 409 328 5 119
METFORMIN HCL 409 223 5 8
LISINOPRIL 383 217 7 3
ZOLPIDEM TARTRATE 333 301 8 24
SIMVASTATIN 304 218 9 1
LEVOTHYROXINE SODIUM 281 207 10 2
FUROSEMIDE 260 191 11 5
PROAIR HFA 258 64 12 50
ENALAPRIL MALEATE 252 141 13 31
DIOVAN 240 193 14 29
PANTOPRAZOLE SODIUM 212 146 15 28
ADVAIR DISKUS 205 74 16 48
TAMSULOSIN HCL 204 163 17 23
AMLODIPINE BESYLATE 199 123 18 4
ATORVASTATIN CALCIUM 199 164 18 11
ATENOLOL 194 163 20 14
ISOSORBIDE MONONITRATE ER 191 186 21 49
HYDROCHLOROTHIAZIDE 175 104 22 13
AZITHROMYCIN 172 93 23 45
OMEPRAZOLE 157 90 24 6
DONEPEZIL HCL 136 131 25 22
LOSARTAN POTASSIUM 131 119 26 17
WARFARIN SODIUM 129 126 27 10
JANUVIA 128 87 28 60
FAMOTIDINE 125 67 29 36
GLIPIZIDE 122 57 30 44
GABAPENTIN 119 60 31 18
LIDODERM 119 101 31 86
CLONIDINE HCL 118 65 33 54
LANSOPRAZOLE 118 95 33 157
CLOPIDOGREL 114 93 35 30
SPIRONOLACTONE 112 71 36 58
NIFEDIPINE ER 105 101 37 59
METOPROLOL TARTRATE 104 86 38 9
CLOTRIMAZOLE-BETAMETHASONE 103 74 39 155
MUPIROCIN 97 59 40 235
PLAVIX 94 75 41 43
SPIRIVA 90 23 42 56
MECLIZINE HCL 89 89 43 120
POTASSIUM CHLORIDE 86 54 44 15
DIOVAN HCT 82 65 45 72
LYRICA 80 46 46 100
VOLTAREN 79 67 47 161
ALENDRONATE SODIUM 78 68 48 21
CELEBREX 75 66 49 99
HYDROCODONE-ACETAMINOPHEN 74 23 S3 50 7
ESCITALOPRAM OXALATE 74 69 50 68
NAPROXEN 73 43 52 95
ACETAMINOPHEN-CODEINE 73 35 S3 52 80
LANTUS 68 0 54 47
MICARDIS 68 54 54 274
POLYETHYLENE GLYCOL 3350 67 46 56 55
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 61 57 35
CARVEDILOL 62 38 58 20
AVODART 59 59 59 164
PROCTOZONE-HC 57 37 60 264
VENTOLIN HFA 55 0 61 101
PAROXETINE HCL 54 44 62 71
GLIPIZIDE XL 53 34 63 140
PRAVASTATIN SODIUM 52 27 64 16
FOSINOPRIL SODIUM 52 52 64 212
LEVOFLOXACIN 51 35 66 77
MELOXICAM 50 42 67 51
TRAMADOL HCL 50 20 67 19
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 26, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.